NovaBay Pharmaceuticals logo
NovaBay Pharmaceuticals NBY
€ 4.06 -15.36%

Quartalsbericht 2025-Q3
hinzugefügt 07.11.2025

report update icon

NovaBay Pharmaceuticals Kurzfristige Verbindlichkeiten 2011-2026 | NBY

Kurzfristige Verbindlichkeiten Jährlich NovaBay Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.84 M 4.28 M 4.26 M 3.44 M 2.83 M 5.69 M 3.85 M 4.98 M 4.32 M 4.63 M 3.34 M 3.63 M 3.17 M 2.84 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
5.69 M 2.83 M 3.86 M

Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Adagene Adagene
ADAG
38.2 M $ 2.62 28.82 % $ 147 M chinaChina
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Zoetis Zoetis
ZTS
3.41 B $ 123.99 -0.31 % $ 56.3 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
195 M $ 67.49 -3.02 % $ 9.03 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 4.51 8.41 % $ 9.81 B israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
174 M $ 25.92 -0.86 % $ 1.26 B usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
1.13 B $ 13.49 -0.66 % $ 4.17 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.66 -1.85 % $ 16.7 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Athersys Athersys
ATHX
29.9 M - 3.77 % $ 22.4 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2.21 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Biogen Biogen
BIIB
5.53 B $ 171.89 -1.1 % $ 25 B usaUSA